Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials

被引：253
作者：
Caster, Joseph M. [1 ]
Patel, Artish N. [1 ]
Zhang, Tian [2 ]
Wang, Andrew [1 ]
机构：
[1] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC 27514 USA
[2] Duke Univ, Dept Med, Durham, NC USA
来源：
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY | 2017年 / 9卷 / 01期
关键词：
CELL LUNG-CANCER; PHASE-III TRIAL; INCORPORATING MICELLAR NANOPARTICLE; ADVANCED SOLID TUMORS; COMPARING PACLITAXEL POLIGLUMEX; GYNECOLOGIC-ONCOLOGY-GROUP; LIPID-BASED PRODRUG; PS; PATIENTS; GENEXOL-PM; PSEUDOMONAS-AERUGINOSA;
D O I：
10.1002/wnan.1416
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
Nanomedicine is a relatively new field that is rapidly evolving. Formulation of drugs on the nanoscale imparts many physical and biological advantages. Such advantages can in turn translate into improved therapeutic efficacy and reduced toxicity. While approximately 50 nanotherapeutics have already entered clinical practice, a greater number of drugs are undergoing clinical investigation for a variety of indications. This review aims to examine all the nanoformulations that are currently undergoing clinical investigation and their outlook for ultimate clinical translation. WIREs Nanomed Nanobiotechnol 2017, 9:e1416. doi: 10.1002/wnan.1416 For further resources related to this article, please visit the .
引用
收藏
页数：18
相关论文
共 84 条
[1]   A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer [J].
Ahn, Hee Kyung ;
Jung, Minkyu ;
Sym, Sun Jin ;
Shin, Dong Bok ;
Kang, Shin Myung ;
Kyung, Sun Young ;
Park, Jeong-Woong ;
Jeong, Sung Hwan ;
Cho, Eun Kyung .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) :277-282
[2]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[3]   Current progress of siRNA/shRNA therapeutics in clinical trials [J].
Burnett, John C. ;
Rossi, John J. ;
Tiemann, Katrin .
BIOTECHNOLOGY JOURNAL, 2011, 6 (09) :1130-1146
[4]   Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis [J].
Caminero, Jose A. ;
Sotgiu, Giovanni ;
Zumla, Alimuddin ;
Migliori, Giovanni Battista .
LANCET INFECTIOUS DISEASES, 2010, 10 (09) :621-629
[5]   Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients [J].
Cantón, R ;
Cobos, N ;
de Gracia, J ;
Baquero, F ;
Honorato, J ;
Gartner, S ;
Alvarez, A ;
Salcedo, A ;
Oliver, A ;
García-Quetglas, E .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) :690-703
[6]   Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection [J].
Clancy, J. P. ;
Dupont, L. ;
Konstan, M. W. ;
Billings, J. ;
Fustik, S. ;
Goss, C. H. ;
Lymp, J. ;
Minic, P. ;
Quittner, A. L. ;
Rubenstein, R. C. ;
Young, K. R. ;
Saiman, L. ;
Burns, J. L. ;
Govan, J. R. W. ;
Ramsey, B. ;
Gupta, R. .
THORAX, 2013, 68 (09) :818-825
[7]   Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis [J].
Coelho, Teresa ;
Adams, David ;
Silva, Ana ;
Lozeron, Pierre ;
Hawkins, Philip N. ;
Mant, Timothy ;
Perez, Javier ;
Chiesa, Joseph ;
Warrington, Steve ;
Tranter, Elizabeth ;
Munisamy, Malathy ;
Falzone, Rick ;
Harrop, Jamie ;
Cehelsky, Jeffrey ;
Bettencourt, Brian R. ;
Geissler, Mary ;
Butler, James S. ;
Sehgal, Alfica ;
Meyers, Rachel E. ;
Chen, Qingmin ;
Borland, Todd ;
Hutabarat, Renta M. ;
Clausen, Valerie A. ;
Alvarez, Rene ;
Fitzgerald, Kevin ;
Gamba-Vitalo, Christina ;
Nochur, Saraswathy V. ;
Vaishnaw, Akshay K. ;
Sah, Dinah W. Y. ;
Gollob, Jared A. ;
Suhr, Ole B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :819-829
[8]   A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days [J].
Cohen, Craig R. ;
Brown, Joelle ;
Moscicki, Anna-Barbara ;
Bukusi, Elizabeth A. ;
Paull, Jeremy R. A. ;
Price, Clare F. ;
Shiboski, Stephen .
PLOS ONE, 2011, 6 (01)
[9]   Phase II, Multicenter, Randomized Trial of CPX-351 (cytarabine: daunorubicin) Liposome Injection Versus Intensive Salvage Therapy in Adults With First Relapse AML [J].
Cortes, Jorge E. ;
Goldberg, Stuart L. ;
Feldman, Eric J. ;
Rizzeri, David A. ;
Hogge, Donna E. ;
Larson, Melissa ;
Pigneux, Arnaud ;
Recher, Christian ;
Schiller, Gary ;
Warzocha, Krzysztof ;
Kantarjian, Hagop ;
Louie, Arthur C. ;
Kolitz, Jonathan E. .
CANCER, 2015, 121 (02) :234-242
[10]   Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer A Phase 2 Trial [J].
Dipetrillo, Thomas ;
Suntharalingam, Mohan ;
Ng, Thomas ;
Fontaine, Jacques ;
Horiba, Naomi ;
Oldenburg, Nicklas ;
Perez, Kimberly ;
Birnbaum, Ari ;
Battafarano, Richard ;
Burrows, Whitney ;
Safran, Howard .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01) :64-67
123456789